166547-20-2

Usage

Uses

Used in Pharmaceutical Industry:
Eurycarpin A is used as a potential therapeutic agent for various health conditions due to its anti-cancer, anti-malarial, and anti-bacterial properties. Its ability to target and inhibit the growth of cancer cells, as well as its potential to combat malaria and bacterial infections, makes it a promising candidate for the development of new drugs and treatments.
Used in Drug Discovery and Development:
Eurycarpin A is used as a key compound in the search for new drug candidates, particularly in the fields of oncology, infectious diseases, and antimicrobial therapy. Its diverse range of biological activities and potential health benefits make it an attractive target for researchers and pharmaceutical companies looking to develop novel and effective treatments.
Used in Anticancer Applications:
Eurycarpin A is used as an anticancer agent, targeting the growth and proliferation of cancer cells. Its ability to inhibit tumor growth and induce cell death makes it a valuable tool in the fight against various types of cancer.
Used in Antimalarial Applications:
Eurycarpin A is used as an antimalarial agent, targeting the Plasmodium parasites responsible for malaria. Its potential to inhibit the growth and replication of these parasites could lead to the development of new and effective treatments for this life-threatening disease.
Used in Antibacterial Applications:
Eurycarpin A is used as an antibacterial agent, targeting the growth and proliferation of bacteria. Its potential to inhibit bacterial growth and combat infections could contribute to the development of new and effective antibiotics, particularly in the face of increasing antibiotic resistance.